Seagen(SGEN) - 2020 Q2 - Earnings Call Presentation

Julie, treated for metastatic breast cancer on a TUKYSA clinical trial Transformative therapies | Targeting cancer 1 Transformative Therapies | Targeting Cancer Today's Agenda SECOND QUARTER 2020 FINANCIAL RESULTS AND BUSINESS UPDATE July 30, 2020 3 . CLAY SIEGALL, Ph.D. President and CEO | INTRODUCTION | Peggy Pinkston, VP, Investor Relations | | --- | --- | | CEO OPENING REMARKS | Clay Siegall, Ph.D., President & CEO | | COMMERCIAL UPDATE | Chip Romp, EVP, Commercial U.S. | | FINANCIAL RESULTS & GUIDANCE ...